16 completed, 6 unknown, 5 recruiting, 2 active not recruiting. 15 Not applicable, 7 Phase 2, 6 Phase 3, 3 Phase 4, 2 Phase 1.
Follow Active treatment: new trials by email Literature Review of Active treatment trials Research Report on Active treatment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis Active treatment, Sham (No Treatment) - Rheumatoid Arthritis | Not applicable | Recruiting | Surf Therapeutics | 40 | 2026-03-20 | 2026-07-07 |
| The Effectiveness of a Herbal Supplement in Osteoarthritis. Active treatment, Placebo - Osteoarthritis (OA), Osteoarthritis (OA) of the Hip | Not applicable | Recruiting | Middlesex University | 30 | 2025-12-05 | 2026-01-29 |
| The SWITCH (Substitution of High With Low Ultra-processed Soy Protein Foods In a Guideline-based Diet inTervention for Cardiometabolic Health) Trial Reference Treatment, Control, Active Treatment - Hypertension in Type 2 Diabetes, Diabetes Mellitus Type 2 | Not applicable | Recruiting | University of Toronto | 300 | 2025-08-06 | 2026-05-04 |
| A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata Ritlecitinib higher dose, Ritlecitinib lower dose, Placebo - Severe Alopecia Areata | Phase 3 | Active not recruiting | Pfizer | 208 | 2025-07-31 | 2026-08-26 |
| Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain Active Treatment, Non-active Treatment - Pain, Nerve | Phase 2 / Phase 3 | Recruiting | Stanford University | 95 | 2024-11-01 | 2026-04-24 |
| Accelerated Transcranial Magnetic Stimulation in Treatment-Resistant Depressed Patients Transcranial Magnetic Stimulation with figure-eight coil - Treatment Resistant Depression (TRD), Transcranial Magnetic Stimulation | Not applicable | Completed | Ataturk University | 50 | 2024-11-01 | 2026-06-04 |
| Investigating the Effects of Dietary Phospholipids on Stress Reactivity and Recovery Active, Placebo - Mood, Stress | Not applicable | Completed | Northumbria University | 150 | 2024-01-02 | 2025-09-11 |
| Investigating the Effects of Dietary Phospholipids on Measures of Human Brain Health and Psychological Wellbeing Active, Placebo - Mood, Cognitive Change | Not applicable | Completed | Northumbria University | 119 | 2024-01-02 | 2026-06-25 |
| Effectiveness of TDCS Over Broca's Area in Verb Naming: a Randomized, Double-Blind, Crossover Study Active treatment, Sham Stimulation - Aphasia Non Fluent, Stroke | Not applicable | Completed | I.R.C.C.S. Fondazione Santa Lucia | 32 | 2023-12-04 | 2025-01-15 |
| Chinese Medicine for Treating Chronic Pharyngolaryngitis Qingyan Lihou Decoction, Placebo - Chronic Pharyngolaryngitis (Disorder) | Phase 2 | Recruiting | Chinese University of Hong Kong | 74 | 2023-03-30 | 2026-07-30 |
| Evaluation of the Long Term Efficacy and Durability of the BrainsWay Deep TMS in OCD Subjects BrainsWay Deep TMS HAC/H7-Coil, BrainsWay Deep TMS Sham Coil - Obsessive-Compulsive Disorder | Not applicable | Unknown | Brainsway | 124 | 2022-08-01 | 2022-07-20 |
| Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients Sulfasalazine, Placebos - Breast Cancer, Chronic Pain Due to Malignancy (Finding) | Phase 2 | Completed | University of Arizona | 7 | 2021-05-03 | 2025-01-09 |
| Oral Ibuprofen Versus Placebo in Treatment of Patent Ductus Arteriosus (PDA)in Preterm Infants Ibuprofen oral suspension, Placebo - Patent Ductus Arteriosus After Premature Birth, Patent Ductus Arteriosus Conservative Management | Phase 2 | Completed | Nada Youssef | 80 | 2021-04-15 | 2023-02-28 |
| Prospective US Radiofrequency SUI Trial Active treatment, Sham - Urinary Incontinence, Stress | Not applicable | Unknown | Viveve Inc. | 390 | 2021-01-11 | 2021-07-26 |
| Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain Prasterone 6.5 MG, Placebo - Vulvovaginal Atrophy | Phase 3 | Unknown | Dr. Santiago Palacios | 50 | 2020-12-22 | 2021-06-02 |
| Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis) miconazole 2% oil, vehicle oil - Otomycosis | Phase 2 / Phase 3 | Completed | Hill Dermaceuticals, Inc. | 382 | 2020-07-08 | 2024-01-19 |
| The Effect of Zoledronic Acid on Patients With Osteoarthritis of the Hip Zoledronic Acid, Saline 0.9% - Osteoarthritis, Hip | Phase 3 | Unknown | Vestre Viken Hospital Trust | 70 | 2020-03-02 | 2022-10-24 |
| Multi-site Transcranial Magnetic Stimulation Therapy of the Supplementary Motor Area in Children With Tourette Syndrome Active Treatment, Sham Treatment - Tourette Syndrome | Not applicable | Withdrawn | Children's Mercy Hospital Kansas City | 2019-07-01 | 2022-02-15 | |
| IV Steroids Versus Steroids Included in Block for Orthopedic Lower Limb Surgery Placebos, Dexamethasone Sodium Phosphate - Lower Limb Injury | Early Phase 1 | Completed | University of Arizona | 50 | 2019-06-05 | 2021-07-21 |
| Management of the PDA Trial Active Treatment, Expectant Management - Infant, Premature, Patent Ductus Arteriosus | Phase 3 | Active not recruiting | NICHD Neonatal Research Network | 482 | 2019-02-22 | 2026-05-12 |
Showing 20 of 31. Sign in to see all of them.
Dyslipidemias (2) · Osteoarthritis, Hip (2) · Signs and Symptoms (2) · Alopecia Areata (1) · Aphasia (1) · Aphasia, Broca (1) · Arthritis, Rheumatoid (1) · Breast Neoplasms (1) · Communication Disorders (1) · Community-Acquired Pneumonia (1) · Coronary Artery Disease (1) · Depressive Disorder, Treatment-Resistant (1) · Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1) · Ductus Arteriosus, Patent (1)
Northumbria University (2) · Pfizer (2) · University of Arizona (2) · Viveve Inc. (2) · 4Life Research, LLC (1) · Ajou University School of Medicine (1) · Ataturk University (1) · Boston VA Research Institute, Inc. (1) · Brainsway (1) · Children's Mercy Hospital Kansas City (1) · Chinese University of Hong Kong (1) · David Garcia Cinca (1) · Dompé Farmaceutici S.p.A (1) · Dr. Santiago Palacios (1) · Encore Vision, Inc. (1)
United States (14) · United Kingdom (4) · Canada (3) · Italy (3) · Spain (3) · Belgium (1) · China (1) · Czechia (1) · Egypt (1) · France (1) · Germany (1) · Hong Kong (1) · Israel (1) · Japan (1) · Jordan (1)
Arnaldo Rivera, MD (1) · Brent Benscoter, MD (1) · Carlo Caltagirone, MD, PhD (1) · David Vollmer, PhD (1) · Emanuele Bosi, MD (1) · Eric S Rovner, MD (1) · Erik F Eriksen, MD, PhD (1) · Gary Brandt, MD (1) · Jeffrey Adelglass, MD (1) · John Ansley, MD (1) · Keith A Coffman, M.D. (1) · Kenneth Hodge, MD (1) · Linda Woo, MD (1)
PMID 35315341, PMID 37409229, PMID 41364689
2014 (1), 2019 (1), R21CA245411 (1), UG1HD112079 (1), UG1HD112097 (1), UG1HD112100 (1)